Ensayo Tuberculino
Shajo Kunnath-Velayudhan and Maria Laura Gennaro Clin. Microbiol. Rev. 2011, 24(4):792. DOI: 10.1128/CMR.00014-11.
Updated information and services can be found at: http://cmr.asm.org/content/24/4/792 These include:
REFERENCES
Downloaded from http://cmr.asm.org/ on October 1, 2012 by guest
This articlecites 188 articles, 71 of which can be accessed free at: http://cmr.asm.org/content/24/4/792#ref-list-1 Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), more»
CONTENT ALERTS
Information about commercial reprint orders: http://journals.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to:http://journals.asm.org/site/subscriptions/
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2011, p. 792–805 0893-8512/11/$12.00 doi:10.1128/CMR.00014-11 Copyright © 2011, American Society for Microbiology. All Rights Reserved.
Vol. 24, No. 4
Immunodiagnosis of Tuberculosis: a Dynamic View of Biomarker Discovery
Shajo Kunnath-Velayudhan and Maria Laura Gennaro*
The Public Health Research Institute, New Jersey Medical School,225 Warren Street, Newark, New Jersey 07103 INTRODUCTION .......................................................................................................................................................792 THE GRANULOMATOUS LESIONS .....................................................................................................................793 The Tuberculous Granuloma................................................................................................................................793 Priming in the Granuloma ....................................................................................................................................794 Bacterial Phenotypes and Antigen Expression...................................................................................................795 Local and Systemic Immune Responses..............................................................................................................795 IMMUNE MARKERS ................................................................................................................................................796 Mediators of Antigen-Specific ImmuneResponses............................................................................................796 Cellular Immune Responses and Infection State...............................................................................................797 Cellular responses in latent infection and active TB ....................................................................................797Cellular responses and antigen expression.....................................................................................................798 Cellular responses and disease progression ...................................................................................................798 Humoral Immune Responses and Infection State.............................................................................................798 Antibody responses and bacterial metabolic status.......................................................................................798 Antibody responses and bacterial burden .......................................................................................................799 Antibody responses and diseaseprogression..................................................................................................799 Diversity of antibody responses ........................................................................................................................799 NEW PRINCIPLES FOR BIOMARKER DISCOVERY........................................................................................800 A Paradigm Shift...
Regístrate para leer el documento completo.